F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on observation, interview, and record review, for one of five sampled residents (Resident 38) who
were reviewed for unnecessary medications use, the facility failed to ensure:
1. Resident 38 was given antipsychotic medication (medication to help reduce psychotic symptoms like
hallucinations, delusions, and disordered thinking) to treat a specific condition.
2. Resident 38 was given antipsychotic medication with adequate monitoring of adverse effects from the
medication.
These failures had the potential to result in unnecessary use of antipsychotic medication and delayed
management of adverse effects.
Findings:
During a review of Resident 38's admission Record, the admission Record indicated Resident 38 was
admitted to the facility in January 2024 with diagnoses that included Parkinson's disease (a brain disorder
that causes unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance
and coordination) without dyskinesia (uncontrolled, involuntary movement), type 2 diabetes mellitus (a
long-term (chronic) disease in which the body cannot regulate the amount of sugar in the blood) and
dementia (a loss of brain function that occurs with certain diseases, affecting one or more brain functions
such as memory, thinking, language, judgment, or behavior).
During review of Resident 38's Order Summary Report, the Order Summary Report indicated an order
dated 3/1/24 for Resident 38 to receive quetiapine (an antipsychotic medication used to regulate mood,
behaviors, and thoughts) 25 milligram (mg) one tablet by mouth every evening for agitation and behavioral
issues related to Parkinson's disease. The Order Summary Report also indicated for staff to monitor
Resident 38 for the following behaviors related to antipsychotic use: 0=none; 1= afraid; 2= agitated;
3=angry; 4=anxious; 5= mood change; 6= noisy; 7= restless; 8=withdrawn/crying; 9=crying; 10=combative.
The Order Summary Report did not indicate any monitoring for adverse reactions from quetiapine.
During a review of Resident 38's Medication Administration Record (MAR), dated March 2024, the MAR
indicated Resident 38 received seroquel starting 3/3/24. The MAR indicated Resident 8 had 0 behaviors all
shifts from 3/4/24 to 3/19/24. The MAR did not indicate Resident 38 was monitored for presence of adverse
reactions from quetiapine.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
555418
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555418
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/22/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St Francis Healthcare Center
718 Bartlett Ave
Hayward, CA 94541
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 3/19/24 at 11:17 a.m. with Licensed Vocational Nurse (LVN) 1, LVN 1 stated not
knowing if Resident 38 had any negative behavior.
During an interview on 3/19/24 at 12:19 p.m. with Certified Nursing Assistant (CNA) 1, CNA 1 stated
Resident 38 was calm when up in the wheelchair but got restless when back to bed. CNA 1 stated Resident
38 would want to be back to bed when up in the wheelchair only to ask to be back up in the wheelchair
after going to bed. CNA 1 also stated Resident 38 moved a lot in bed needing frequent checks by staff for
safety.
During a follow-up interview and concurrent review of clinical records on 3/19/24 at 12:27 p.m. with LVN 1,
Resident 38's MAR from January 2024 to March 2024 was reviewed. LVN 1 stated the MAR for March 2024
indicated Resident 38 had no behaviors during the morning, afternoon, and night shifts. LVN 1 also stated
the MAR indicated there was no monitoring for adverse effects from seroquel use. LVN 1 stated, adverse
effects that staff should watch out for include drowsiness, increased behavior episodes and nausea (feeling
an urge to vomit).
During an interview and concurrent review of clinical records on 3/19/24 at 1:52 p.m. with Minimum Data
Set Coordinator (MDSC), MDSC stated, in January 2024, pain management was revised to address
agitation and behaviors which did not help. MDSC stated, on 2/29/24, Resident 38 was re-evaluated by
rehabilitation team with the goal to continue therapy to help with pain management, but Resident 38's
participation with therapy did not improve, so quetiapine was started to address agitation.
During a review of Resident 38's Psychological Assessment, dated 3/6/24, the Psychological Assessment
indicated Resident 38's presenting problem: Agitation/Combative, mental status: confused but pleasant and
cooperative. The Psychological Assessment indicated Resident 38 was Restarted 3/1 on quetiapine.
During an interview on 3/19/24 at 3:11 p.m. with Registered Nurse (RN) 1, RN 1 stated Resident 38's only
behavior in the evening shift was calling out and talking a lot but never physically restless even after being
helped back to bed.
During a review of Resident 38's care plans, the care plans indicated there was no care plan to address
use of quetiapine.
During a review of quetiapine's Product Monograph, last revised 11/29/21, the Product Monograph
indicated an Increased mortality in elderly patients with dementia. It further indicated elderly patients with
dementia treated with quetiapine are at an increased risk of death, of which cause of death varied to be
either cardiovascular (a general term for conditions affecting the heart or blood vessels) or infectious in
nature. The Product Monograph indicated most commonly adverse drug reactions included somnolence (a
state of drowsiness or strong desire to fall asleep), dizziness, dry mouth, elevations in serum triglyceride (a
type of fat, called lipids, that circulate in your blood), elevation in low density lipoprotein cholesterol (LDL,
sometimes called bad cholesterol, makes up most of your body's cholesterol. High levels of LDL cholesterol
raise your risk for heart disease and stroke) and decrease in high density lipoprotein cholesterol
(sometimes called good cholesterol, absorbs cholesterol in the blood and carries it back to the liver. The
liver then flushes it from the body. High levels of HDL cholesterol can lower your risk for heart disease and
stroke), weight gain, decreased hemoglobin (a protein in your red blood cells that carries oxygen to your
body's organs and tissues and transports carbon dioxide from your organs and tissues back to your lungs)
and extrapyramidal symptoms (movement dysfunction such as continuous spasms and muscle
contractions, motor
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555418
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555418
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/22/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St Francis Healthcare Center
718 Bartlett Ave
Hayward, CA 94541
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
restlessness, rigidity, slowness of movement, tremor, and irregular, jerky movements).
Level of Harm - Minimal harm
or potential for actual harm
During a review of the facility's policy and procedure (P&P) titled Antipsychotic Medication Use, last revised
July 2022, the P&P indicated the following:
Residents Affected - Few
1. Residents will only receive antipsychotic medications when necessary to treat a specific condition for
which it is indicated for.
2. Antipsychotic medications shall generally be used only for the following conditions as documented in the
record .: a. schizophrenia (serious mental disorder in which people interpret reality abnormally, may result
in hallucinations, delusions and extremely disordered thinking and behavior), b. schizoaffective disorder (a
mental disorder characterized by abnormal thought processes and an unstable mood), c. schizophreniform
disorder (mental health disorder that causes symptoms of psychosis like hallucinations, delusions and
disorganized speech), d. delusional disorder (one or more firmly held false beliefs), e. mood disorders ., f.
psychosis in the absence of dementia, g. medical illness with psychotic symptoms and/or treatment-related
psychosis or mania .h. Tourette's Disorder ( involves repetitive movements or unwanted sounds (tics) that
can't be easily controlled), i. Huntington Disease (causes progressive breakdown of the brain's nerve cells),
j. hiccups (not induced by medications) or k. nausea and vomiting associated with cancer or chemotherapy
(cancer treatment that uses powerful chemicals to kill fast-growing cells in your body).
3. Antipsychotic medications will not be used if the only symptoms are one or more of the following: a.
wandering; b. poor self-care; c. restlessness; d. impaired memory; e. mild anxiety; f. insomnia; g. inattention
or indifference to surroundings; h. sadness or crying alone that is not related to depression or other
psychiatric disorders; i. fidgeting; j. nervousness; or k. uncooperativeness.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555418
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555418
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/22/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
St Francis Healthcare Center
718 Bartlett Ave
Hayward, CA 94541
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0836
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure the facility is licensed under applicable State and local law and operates and provides services in
compliance with all applicable Federal, State, and local laws, regulations, and codes, and with accepted
professional standards.
Based on interview and record review, the facility failed to operate and provide services in compliance with
State regulations when an unusual occurrence of a fall with major injury was not reported to the State
Agency.
This failure had the potential to result in the lack of oversight for resident safety.
Findings:
During a review of Resident 7's Progress Notes, dated 3/8/24, the Progress Notes indicated Resident 7
was found sitting on the floor at the bedside while getting ready for the day. The Progress Notes indicated
Resident 7 went to a day program but was sent back to the facility after vomiting and verbalizing Not feeling
well.
During a review of Resident 7's Radiology Results Report, dated 3/9/24, the Radiology Results Report
indicated a vertebral compression fracture at L1.
During a review of Resident 7's SNF/NF to Hospital Transfer Form, dated 3/9/24, and Patient Visit
Information, dated 3/10/24, the Transfer Form indicated Resident 7 was transferred to the hospital for
further management on 3/9/24. The Patient Visit Information indicated Resident 7 returned to the facility the
next day, 3/10/24, with diagnoses that included closed fracture lumbar vertebra.
During an interview on 3/20/24 at 12:07 p.m. with Certified Nursing Assistant (CNA) 2, CNA 2 stated, since
the fall incident, Resident 7 could not have the head of bed elevated long enough to drink or eat enough.
CNA 2 stated Resident 7's pain has caused Resident 7 so much confusion that Resident 7 did not know
what she wanted.
During an interview on 3/20/24 at 1:06 p.m. with Administrator (Adm), Adm stated Resident 7's fall was not
reported to the State Agency because Adm stated not being aware of a requirement to report falls with
major injuries. Adm stated the facility did not have a policy and procedure to address reporting of falls with
major injury such as fractures.
During a review of Barclays California Code of Regulations Title 22, Title 22 indicated, under Article 5.
Administration, Section 72541, Unusual Occurrences, occurrences such as major accidents which threaten
the welfare, safety or health of patients shall be reported by the facility within 24 hours either by telephone
(and confirmed in writing) to the local health officer and the Department.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555418
If continuation sheet
Page 4 of 4